These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35600045)

  • 1. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-naïve schizophrenia patients with acute phase.
    Zheng Y; Zhang Q; Zhou X; Yao L; Zhu Q; Fu Z
    Sci Rep; 2023 Dec; 13(1):21711. PubMed ID: 38066312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could we use PD-1 and PD-L1 expression on lymphocytes and monocytes as predictive markers for prognosis of acute biliary pancreatitis?
    Idiz UO; Aru B; Kaya C; Peker KD; Tatar C; Guler M; Tunay A; Demirel GY; Gurol AO
    Immunol Lett; 2024 Feb; 265():37-43. PubMed ID: 38199503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percentages of PD-1
    Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
    Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of PD-1/PD-L1 signaling axis on the interaction between CD19
    Xie Z; Dai L; He H; Hong D; Tang H; Xu W; Chen Z; Wang H; Li B; Xie C; Wang Y
    Adv Rheumatol; 2023 Oct; 63(1):51. PubMed ID: 37848996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
    Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
    Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation.
    Yang W; Li H; Chen PW; Alizadeh H; He Y; Hogan RN; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):273-80. PubMed ID: 18791172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides.
    Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4
    Awad RM; De Vlaeminck Y; Meeus F; Ertveldt T; Zeven K; Ceuppens H; Goyvaerts C; Verdonck M; Salguero G; Raes G; Devoogdt N; Breckpot K
    Sci Rep; 2023 Nov; 13(1):18995. PubMed ID: 37923822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
    Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
    PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease.
    Chen KY; Sun WL; Wu SM; Feng PH; Lin CF; Chen TT; Lu YH; Ho SC; Chen YH; Lee KY
    Cells; 2024 May; 13(10):. PubMed ID: 38786101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
    Hirayama A; Tanaka K; Tsutsumi H; Nakanishi T; Yamashita S; Mizusaki S; Ishii Y; Ota K; Yoneshima Y; Iwama E; Okamoto I
    Front Immunol; 2023; 14():1192861. PubMed ID: 37441079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.
    Altves S; Guclu E; Yetisgin E; Bilecen K; Vural H
    World J Microbiol Biotechnol; 2024 May; 40(7):204. PubMed ID: 38755413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis.
    Coman O; Grigorescu BL; Huțanu A; Bacârea A; Văsieșiu AM; Fodor RȘ; Stoica F; Azamfirei L
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064603
    [No Abstract]   [Full Text] [Related]  

  • 15. Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/Akt/mTOR and RAS/MEK/ERK signalling pathways.
    Fu S; Li J; You J; Liu S; Dong Q; Fu Y; Luo R; Sun Y; Tian X; Liu W; Zhang J; Ding Y; Zhang Y; Wang W; Guo L; Qiu Y
    Vet Res; 2024 Jul; 55(1):95. PubMed ID: 39075562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling.
    Bazhin AV; von Ahn K; Fritz J; Werner J; Karakhanova S
    Front Immunol; 2018; 9():2129. PubMed ID: 30356906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1/PD-L1 governed cross-talk of exhausted CD8
    Wang K; Zhao J; Feng X; He S; Li J; Sun F; Xu Z; Yang H; Ye J; Cao L; Ye S
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38233074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
    Zhang M; Wan Y; Han J; Li J; Gong H; Mu X
    PeerJ; 2024; 12():e16988. PubMed ID: 38560459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
    Okuyama M; Mezawa H; Kawai T; Urashima M
    Front Immunol; 2019; 10():86. PubMed ID: 30833943
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenicity of functionally activated PD-1
    Sasaki H; Umezawa N; Itakura T; Iwai H; Yasuda S
    J Autoimmun; 2024 Jan; 142():103131. PubMed ID: 37931332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.